Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

Officer Henn Matthew R converted options into 239 shares and sold $754 worth of shares (89 units at $8.47), increasing direct ownership by 2% to 7,677 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.